CIK 0001438533 · Large accelerated filer
Travere Therapeutics, Inc.
Sign in to watch- Ticker
- TVTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 262383102
- Phone
- 888-969-7879
- Business address
- 3611 VALLEY CENTRE DR, SUITE 300, SAN DIEGO, CA, 92130
- Former names
- Retrophin, Inc., Desert Gateway, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $80,128,453
- in 11 filings, $80.1M under 10b5-1 plans
Net −$80,128,453. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Dube Eric M −$38.5M CHIEF EXECUTIVE OFFICER sold 60% of stake
- Heerma Peter −$17.9M EVP, CHIEF COMMERCIAL OFFICER sold 71% of stake
- ROTE WILLIAM E. −$13.1M Chief Research Officer sold 68% of stake
- Cline Christopher R. −$3.2M CHIEF FINANCIAL OFFICER sold 37% of stake
- Inrig Jula −$2.8M EVP, Head of R&D & CMO sold 31% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-05 | Rosenberg Noah L. Chief Medical Officer | Sale | −1,125 | $31.41 | $35K | 47,469 |
| 2021-02-05 | Heerma Peter Chief Commercial Officer | Sale | −1,125 | $31.41 | $35K | 60,469 |
| 2021-02-05 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −2,250 | $31.41 | $71K | 39,582 |
| 2021-02-05 | REED ELIZABETH E SVP, GC & Corporate Secretary | Sale | −2,250 | $31.41 | $71K | 39,955 |
| 2021-02-05 | Clague Laura Chief Financial Officer | Sale | −2,250 | $31.41 | $71K | 34,473 |
| 2021-02-05 | Dube Eric M Chief Executive Officer | Sale | −4,813 | $31.41 | $151K | 161,626 |
| 2021-02-04 | ASELAGE STEVE Director | Gift | −25,000 | 164,794 | ||
| 2021-02-04 | ASELAGE STEVE Director | Gift | +25,000 | 25,000 | ||
| 2021-02-03 | Rosenberg Noah L. Chief Medical Officer | Grant or award | +4,500 | 48,594 | ||
| 2021-02-03 | ROTE WILLIAM E. Senior Vice President, R&D | Grant or award | +4,500 | 41,832 | ||
| 2021-02-03 | Heerma Peter Chief Commercial Officer | Grant or award | +4,500 | 61,594 | ||
| 2021-02-03 | REED ELIZABETH E SVP, GC & Corporate Secretary | Grant or award | +4,500 | 42,205 | ||
| 2021-02-03 | Clague Laura Chief Financial Officer | Grant or award | +4,500 | 36,723 | ||
| 2021-02-03 | Dube Eric M Chief Executive Officer | Grant or award | +17,500 | 166,439 | ||
| 2021-02-03 | Heerma Peter Chief Commercial Officer | Sale | −563 | $28.91 | $16K | 57,094 |
| 2021-02-03 | Rosenberg Noah L. Chief Medical Officer | Sale | −1,250 | $28.91 | $36K | 44,657 |
| 2021-02-03 | Rosenberg Noah L. Chief Medical Officer | Sale | −563 | $28.91 | $16K | 44,094 |
| 2021-02-03 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −2,500 | $28.91 | $72K | 38,457 |
| 2021-02-03 | ROTE WILLIAM E. Senior Vice President, R&D | Sale | −1,125 | $28.91 | $33K | 37,332 |
| 2021-02-03 | REED ELIZABETH E SVP, GC & Corporate Secretary | Sale | −2,500 | $28.91 | $72K | 38,380 |
Page 37 of 51 · 1,020 trades